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EdemaLymph hearts are pulsatile organs, present in lower vertebrates, that function to propel lymph into the
venous system. Although they are absent in mammals, the initial veno-lymphatic plexus that forms during
mammalian jugular lymph sac development has been described as the vestigial homologue of the nascent
stage of ancestral anterior lymph hearts. Despite the widespread presence of lymph hearts among vertebrate
species and their unique function, extremely little is known about lymph heart development. We show that
Xenopus anterior lymph heart muscle expresses skeletal muscle markers such as myoD and 12/101, rather
than cardiac markers. The onset of lymph heart myoblast induction can be visualized by engrailed-1 (en1)
staining in anterior trunk somites, which is dependent on Hedgehog (Hh) signaling. In the absence of Hh
signaling and upon en1 knockdown, lymph heart muscle fails to develop, despite the normal development of
the lymphatic endothelium of the lymph heart, and embryos develop edema. These results suggest a
mechanism for the evolutionary transition from anterior lymph hearts to jugular lymph sacs in mammals.).
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The lymphatic system is crucial for proper ﬂuid homeostasis–it
drains interstitial ﬂuid (lymph) from tissues and returns it to the
blood supply. While skeletal muscle contractions circulate lymph in
mammals, lymph hearts have been documented in ﬁsh, amphibians,
reptiles, and birds (Kampmeier, 1969). Lymph hearts are found at the
junctions of the lymphatic and venous systems and serve as a
mechanism to pump lymph throughout the lymphatic system and
into the veins. In frogs, a pair of anterior lymph hearts arises dorso-
caudal to the pronephroi, between the myotomes and the skin,
during tailbud stages (Kampmeier, 1922). Four pairs of posterior
lymph hearts develop during late tadpole stages and connect to the
dorsal subcutaneous lymph sacs during metamorphosis, then regress;
in adult Xenopus, only two pairs of posterior lymph hearts remain
(Nieuwkoop and Faber, 1967). The development of anuran lymphatic
vasculature begins at approximately the same time and location of the
anterior lymph hearts (Kampmeier, 1922). A plexus of vessels appears
on the outer face of the ﬁrst four myotomes, as lateral outgrowths ofthe intersegmental veins. The primordium of the anterior lymph heart
appears at the 3rd segmental vein. As the lymph stream begins to ﬂow
towards the exits in the venous system, the plexus progressively loses
all connections with the veins except at the lymph hearts, through an
undescribed mechanism. Although lymph hearts are absent in
mammals, the initial veno-lymphatic plexus that forms during
mammalian jugular lymph sac development has been described as
the vestigial homologue of the nascent stage of the frog anterior
lymph heart (Kampmeier, 1960). The plexus is the transient
forerunner of the jugular lymph sac anlagen, which develops in the
same location.
Lymph hearts consist of three tissue layers (Satoh and Nitatori,
1980). The inner tunica intima consists of an endothelial cell lining
with supportive connective tissue. The middle tunica media contains
the musculature of the lymph heart, while the outer tunica externa is
made up of ﬁbroelastic tissue. In mammals and Xenopus, lymphatic
vessels (endothelium) have been shown to arise from the blood
vasculature, and require the function of the homeobox transcription
factor prox1 (Ny et al., 2005; Sabin, 1902, 1904; Wigle and Oliver,
1999). On the other hand, the origin of lymph heart musculature has
been controversial. Most notably, Knower (1908) described anuran
lymph heart musculature arising from the adjacent myotomes, while
Kampmeier (1969) speciﬁcally refutes this claim and describes lymph
heart myoblasts as mesenchymal cells that lie lateral to the
myotomes. Recent studies indicate that the endothelium and
musculature of chick lymph hearts arise from the somites (Valasek
et al., 2007; Wilting et al., 2006).
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Xenopus laevis, focusing on the origin and development of the
musculature. We show that lymph heart myoblasts express en1 and
are under distinct developmental control from the associated
lymphatic endothelium, which expresses prox1. Inhibiting the Hh
pathway leads to an absence of en1-positive myoblasts and a
subsequent loss of lymph heart muscle, while prox1-positive lym-
phatic tissue is not affected, and embryos develop edema. Speciﬁc
paralysis of the lymph heart with benzocaine also results in edema,
emphasizing the importance of the lymphatic system for maintaining
proper ﬂuid balance. Timed cyclopamine administration reveals that
the requirement for Hh signaling in lymph heartmyogenesis coincides
with the onset of en1 expression in lymph heart myoblasts, indicating
that loss of En1 causes loss of lymphaticmusculature upon blockade of
Hh signaling. Indeed,we show that Engrailed-1 function is required for
development of the lymph heart musculature but not endothelium.
The results suggest that changes in the developmental pathway
controlling lymph heart muscle development may be responsible for
the evolutionary loss of lymph hearts.
Methods
General methods and microinjection
Xenopus laevis embryos were generated, microinjected, and
cultured by standard methods (Sive et al., 2000). Microinjections
(10 nL) were performed at the 2-cell stage, unilaterally or bilaterally,
with 4 ng ﬂuoresceinated standard control morpholino (Gene Tools,
LLC) plus Engrailed-1 morpholinos as follows: En1 MO1 (5′ TGCAG-
CAGCAAAGTAAGTAGCCCCC) 20 ng, and En1 MO2 (5′ TCAGTTT-
GATCCTCCATGTTATCGC) 10 ng. Embryos were allowed to develop in
0.3X Marc's Ringer (MR) solution and staged according to the normal
table (Nieuwkoop and Faber, 1967).
Whole mount in situ hybridization, antibody staining, and sectioning
Embryos were ﬁxed for 2 h in MEMFA prior to immunohisto-
chemistry or in situ hybridization, which was performed by standard
methods (Sive et al., 2000). Probes were synthesized in vitro with
plasmids digested and transcribed as follows: MyoD–XbaI/SP6 (Hop-
wood and Gurdon, 1990), GATA4–EagI/T3 (Jiang and Evans, 1996),
cardiac troponin–NotI/T7 (Drysdale et al., 1994), cardiac actin–PvuII/
SP6 (Mohun et al., 1984), engrailed-1–XbaI/SP6 (Eizema et al., 1994),
prox1–NcoI/SP6 (Schaefer et al., 1999), Msr–NotI/T7 (Devic et al.,
1996), VEGF–BamHI, T7 and Flk-1–NotI, T7 (Cleaver et al., 1997). The
muscle-speciﬁc 12/101 monoclonal antibody was used undiluted to
visualize differentiated skeletal muscle (Kintner and Brockes, 1984),
followed by goat anti-mouse IgG secondary antibody (HRP, Jackson
ImmunoResearch, 1:100 or AlexaFluor 488, Invitrogen, 1:200). The
Prox1 polyclonal antibody (Covance) was used at a 1:1000 dilution,
followed by a goat anti-rabbit IgG secondary conjugated to HRP
(BioRad) at a 1:1000 dilution. In cases where both in situ
hybridization and antibody staining were carried out on embryos, in
situ staining was performed ﬁrst, followed immediately by immuno-
histochemistry. To aid in visualization of staining, some embryoswere
cleared with benzyl benzoate/benzyl alcohol (2:1) after thorough
dehydration in methanol. For sectioning, processed embryos were
embedded in 4% lowmelt agarose and sectioned at 50–100 μmusing a
vibratome (Oxford).
Cyclopamine treatment
A stock solution of cyclopamine (LC Laboratories) was made at
10 mM in 100% ethanol and diluted to 100 μM in 1/3x MR for embryo
treatment. Except for time–course experiments, when embryos were
added to cyclopamine at the stages indicated, embryos at stages 8–11were transferred to 1/3x MR+100 μM cyclopamine or 1/3x MR with
an equivalent volume of ethanol (solvent) as a control and allowed to
develop to the desired stage, then ﬁxed in MEMFA.
Benzocaine treatment
A stock solution of benzocaine (ethyl 4-aminobenzoate) wasmade
at 10% in 100% ethanol. Tadpoles with beating lymph hearts (st. 42+)
were incubated in 1/3x MR+0.005%–0.01% benzocaine or an
equivalent volume of ethanol as a control. In benzocaine, lymph
hearts stopped beating within 1 h, while cardiac heartbeat was
unaffected or modestly slowed. Edema developed within 24 h in
benzocaine, after which tadpoles were moved to 1/3x MR to restore
lymph heart function. Recovery of edema occurred within 5 days of
restored lymph heart function.
Lymphangiography
Tadpoles with beating lymph hearts (st. 42+) were anaesthetized
in 0.01% benzocaine and microinjected in the ventral tail ﬁn (Ny et al.,
2005) with 20–50 nl of 25 mg/ml mini-Ruby rhodamine dextran
(Invitrogen). Injected embryos were moved to 1/3x MR for 1 h to
label circulating lymph before being ﬁxed in MEMFA. Embryos were
dehydrated in MeOH and cleared in benzyl benzoate/benzyl alcohol
(2:1) for visualization.
Results and discussion
Lymph heart musculature expresses markers of skeletal, but not
cardiac, muscle
The anterior bilateral lymph hearts in Xenopus, marked by prox1
expression in the lymphatic endothelium, develop at stage 32 at the
3rd segmental vein between trunk somites 3 and 4 (Nieuwkoop and
Faber, 1967; Ny et al., 2005). EM analysis has shown that the structure
of lymph heart myotubes shares characteristics of both cardiac and
skeletal muscle (Rumyantsev and Krylova, 1990). We examined
several markers to determine the molecular nature of lymph heart
muscle. The 12/101 antibody, which marks differentiated skeletal
muscle but not cardiac muscle (Kintner and Brockes, 1984), was used
to visualize stage 42 tadpole lymph hearts (Figs. 1 A, C, M). At this
stage, bilaterally symmetrical lymph hearts (Fig. 1A) are found
adjacent to trunk somites 3 and 4 (Fig. 1C). In addition, differentiating
lymph hearts also express myoD, another marker speciﬁc to skeletal
and not cardiacmuscle (Hopwood et al., 1989) (Fig. 1B). Despite being
labeled with skeletal muscle markers, the lymph heart myotubes have
a thin branched structure similar to cardiac muscle (Fig. 1C), and
lymph heartmuscles contract in a rhythmicmanner (our observations
and Ny et al., 2005). However, the lymph hearts do not express
determinants of cardiac fate, such as GATA4, -5, and -6 (Fig. 1D–E and
not shown), nor markers of terminal cardiac differentiation, such as
the contractile protein cardiac troponin (Figs. 1F–G) during early (st.
33–34) or late (st. 40) stages of lymph heart development. Cardiac
actin is expressed in lymph hearts at stage 40 (Fig. 1I, arrow), as
expected, because this is the ﬁrstα-actin expressed in skeletal muscle
(Mohun et al., 1984), as shown by the signal in the paraxial
mesoderm, hypaxial muscles, and head musculature, as well as the
heart (Figs. 1H, I). The skeletal nature of lymph heart musculature is
consistentwith theobservation that lymphheartmuscle originates from
the somites in the chick, and demonstrates the plasticity of somite-
derivedmyoblasts in their ability to form “cardiac-like” skeletal muscle.
We used lymphangiography (Ny et al., 2005) to conﬁrm that the
structure labeled by the 12/101 antibody is the lymph heart.
Rhodamine-dextran was injected subcutaneously into the ventral
tail ﬁn. Within 1 h, the dye drained rostrally and most of the label was
present in the kidney (Fig. 1J, asterisk). However, labeled cells also
Fig. 1. Lymph heart myoblasts express skeletal muscle markers and not cardiac markers. The 12/101 antibody marks lymph hearts in stage 42 tadpoles (A, C, and M) and MyoD is
expressed in differentiating lymph hearts at stage 40 (B, arrows). Two bilaterally symmetrical lymph hearts can be seen adjacent to the somites (A, B, arrows). The lymph heart forms
in a region adjacent to somites 3 and 4 (C, K, trunk somites are numbered). Lymph heart muscle consists of a meshwork of myotubes (C). The lymph heart does not express cardiac
markers GATA4 (D, E), cardiac troponin (F, G), or cardiac actin (H, I) at st. 33/34 (D, F, and H) or st. 40 (E, G, and I), except for cardiac actin at st. 40 (I, arrow), which marks all
immature muscle (note expression in paraxial and head mesoderm in H, I). Rhodamine-dextran (mini-Ruby) injected subcutaneously into the posterior ventral tail ﬁn drains
anteriorly into the kidney (J, bright spot with asterisk) and into the lymph heart through vessels (J, arrowhead). The labeled lymph heart is located between somites 3 and 4 (K).
Embryos injected with rhodamine-dextran (L, red) and then stained for the skeletal muscle antibody 12/101 (M, green) show co-expression (M', yellow). All lateral views, anterior
left, except for (A, B), which are dorsal views.
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heart between somites 3 and 4 (Fig. 1J, arrowhead; Fig. 1K). The
lymphatic tissue label (Fig. 1L, red) colocalizes with 12/101 staining
(Fig. 1M, green; compare Figs. 1L to M), with the muscle tissue
encircling the dye-labeled lymphatic tissue, as expected (Fig. 1M').
The developing lymph heart is marked by en1 and prox1
We had previously examined en1 expression in tadpoles and
found that it was expressed in anterior somites (Grimaldi et al., 2004).
We further investigated the possibility that en1-positive cells may be
marking myoblasts that give rise to the lymph heart musculature. To
our surprise, we found that en1 speciﬁcally marks lymph heart
myoblasts and not any other type of myoblast. Weak somitic
expression is ﬁrst seen at stage 28 in the clefts of anterior trunk
somites 3 and 4 (Fig. 2A, arrowheads). Transverse sections show en1somite expression in a region lateral to the differentiated myotome at
the D–V level of the notochord (Fig. 2E, arrowhead). At later stages,
en1 expression intensiﬁes and then condenses into a small region
ventral to the notochord, where the lymph heart will form (Fig. 2,
B–D, F–G). At stage 39, bilateral expression of en1 in the lymph heart
region is very similar to later myoD and 12/101 staining (Fig. 2D,
Figs. 1A, B). While en1 expression ﬁrst appears on the same
dorsoventral plane as the notochord (Figs. 2E, F), en1-positive cells
progressively coalesce in a region ventral to the notochord, where the
lymph heart forms (Fig. 2G, compared to 2L). The mature lymph
hearts are found directly above the pronephric tubules and glomus
(Fig. 2L), but arise from a distinct area in the somitic mesoderm, as
opposed to intermediate mesoderm, from which the latter tissues
form (Fig. 2E and Supplemental Figure 1).
The inner layer of lymph hearts consists of lymphatic endothelial
cells (Satoh and Nitatori, 1980). The development of lymphatic
Fig. 2. en1 and prox1 label the developing lymph heart musculature and endothelial tissue, respectively. The expression of en1 is localized to the mid-hindbrain boundary, spinal
interneurons, and anterior somites. The onset of somitic expression occurs at stage 28 (A) in a superﬁcial region on a horizontal plane with the notochord (E, arrowhead, middle of
notochord indicated by red line). The expression does not overlap with 12/101 staining in the differentiated muscle (green). Lateral views show early expression in the anterior
somites (A–B, arrowheads), which intensiﬁes and moves ventrally to occupy the ﬁnal position of the lymph heart (C–D, G). A transverse section of a stage 33 tadpole (F) shows the
intensity of expression increasing. By stage 37 (G), en1-positive cells have moved ventrally relative to the position of the notochord (red line) and are found directly above the
glomus (arrow) and pronephric tubules (arrowhead). At stage 40, prox1 RNA (blue, H, J, and L) and Prox1 protein (brown, I, K, and M) are localized to the developing endothelial
tissue of the lymph heart (H, I, arrows). (J, K) Higher magniﬁcation views of H and I illustrate the budding lymphatic vasculature dorsal to the lymph heart (arrowheads). (L) The
expression of prox1 is slightly ventral to the notochord (red line) and dorsal to the pronephron (arrow) and does not overlap with differentiated muscle (12/101, green). (M) Prox1
(brown) and en1 (blue) expressing cells co-localize at the site of lymph heart formation (arrow). The epidermis has sloughed off during the processing of this embryo.
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of the homeobox transcription factor Prox1 (Wigle and Oliver, 1999),
and the expression of prox1 RNA in Xenopus lymph hearts has been
reported previously (Ny et al., 2005). We reexamined prox1 RNA
expression as well as Prox1 protein in order to compare the timing
and location of expression to that of en1. At stage 39, Prox1 RNA and
protein are both detected in a region similar to en1 expression at this
stage, adjacent to trunk somites 3 and 4 (Figs. 2H, I) and slightly
ventral to the notochord (Fig. 2L). Lymphatic vessels leading out of the
lymph heart are also forming at this stage (Figs. 2J, K arrowheads).
Prox1- and en1-expressing cells co-localize in the region of the
developing lymph heart at this stage (Fig. 2M, arrowhead).
Hh signaling is required for lymph heart muscle development but not
lymphatic tissue
In zebraﬁsh, En proteins mark a speciﬁc subset of somitic cells
called muscle pioneers (Hatta et al., 1991). These form adjacent to the
notochord and are dependent upon Hedgehog (Hh) signals for proper
development (Currie and Ingham, 1996). Similar expression of en1 is
seen in the chicken, where en1-positive cells mark the most lateral
aspect of the epaxial myotome (Cheng et al., 2004; Davis et al., 1991).
Expression of en1 in the chicken is also under positive control by Hh
signaling (Cheng et al., 2004). In order to test whether en1-positive
lymph heart myoblasts might be homologous to en1-positive cells in
the zebraﬁsh and chicken, we exposed embryos to the Hh signaling
inhibitor cyclopamine and examined them for en1 expression and
lymph heart formation. We have previously shown that cyclopamine
can efﬁciently block Hh signaling in Xenopus embryos (Martin et al.,
2007).
Exposure to cyclopaminehad a drastic effect onboth en1 expression
and lymph heart formation. At stage 37, cyclopamine-treated tadpolesdisplay a dramatic reduction of en1 in lymph heart myoblasts, while
neural expression is relatively unaffected (Fig. 3B, 96% with strong en1
reduction in lymph heart myoblasts, N=24), as compared to control
embryos (Fig. 3A, 4% with strong en1 reduction, N=23). Similarly,
stage 42 tadpoles lack visibly beating lymph hearts and 12/101
staining reveals an absence of differentiated lymph hearts (Fig. 3D, 88%
missing 12/101-positive lymph hearts, N=45) as compared to
controls (Fig. 3C, 4% missing 12/101-positive lymph hearts, N=26).
These results indicate that Xenopus lymph heart myoblasts undergo a
similar developmental program as zebraﬁsh pioneer muscle cells and
en1-positive chicken myoblasts.
Surprisingly, cyclopamine-treated embryos exhibited a normal
appearance of Prox1-positive endothelial cells in the lymph heart at
stage 39 and 42 (Figs. 3F, H compared to E, G, cyclopamine-treated
N=9, control N=8). The onlyminor defect appears at stage 42, when
Prox1-positive cells have condensed to form the tunica intima (Fig.
3G, arrowhead). In cyclopamine-treated embryos, these cells are not
as tightly packed (Fig. 3H, arrow), indicating that the musculature of
the tunica media is needed for the proper compaction of the tunica
intima. The loss of lymph heart muscle, but not endothelial cells, in
cyclopamine-treated embryos indicates that these two tissues are
under distinct developmental control. This is interesting in light of the
fact that lymph hearts have been lost in mammals, yet the endothelial
lymphatic structure of the jugular lymph sac forms in the homologous
location in mammals (Kampmeier, 1969).
Hh requirement for lymph heart myoblasts corresponds to the onset of
en1 expression
To further address the requirement for Hh signaling in the
formation of lymph heart myoblasts, we wanted to ascertain whether
the timing of the Hh requirement correlates with the onset of en1
Fig. 3. Lymph heart muscle but not lymphatic endothelium requires Hh signaling. Cyclopamine treatment greatly reduces en1 expression in the somites (23 out of 24 embryos),
while neural expression is relatively unaffected (B compared to A, arrow in A indicates lymph heart expression). At later stages, 12/101 staining shows that lymph heart musculature
is missing in cyclopamine-treated tadpoles (D compared to C, arrow in C indicates lymph heart muscle). The presence of Prox1-positive lymphatic endothelial cells (arrowheads) is
not affected by cyclopamine treatment at stage 39 (F compared to E) or stage 42 (H compared to G). (H) The loss of lymph heart musculature leads to a less compact distribution of
Prox1-positive cells in the lymph heart (arrow).
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mine to embryos at different stages of development and assayed them
for lymph heart myogenesis by 12/101 staining at stage 45 (Fig. 4).
Inhibition of Hh signaling prior to stage 22 resulted in a drastic
reduction in 12/101-positive lymph hearts (4% of embryos with 2
lymph hearts when cyclopamine added at st.20, N=22), and this loss
was signiﬁcantly different from controls until stage 26 (pb0.01, χ2
test). Addition of embryos at stage 26 or later resulted in signiﬁcantly
fewer defects in 12/101 staining, with over 80% (N=22) of embryos
showing bilateral 12/101-positive lymph hearts when cyclopamine
was added at stage 31 (Fig. 4). These results demonstrate that Hh
signaling is required slightly prior to the onset of en1 expression for
the induction of lymph heart myoblasts, and that these en1-positive
cells do not require continuous Hh signaling for later development.Therefore, the onset of en1 expression in lymph heart myoblasts
coincides with the Hh-dependent induction of this tissue.
Loss of lymph heart muscle structure or function results in edema
While beating lymph hearts can be easily identiﬁed under the
dissecting microscope in st. 42+ wild-type tadpoles, those treated
with cyclopamine from gastrula stages do not have beating lymph
hearts. Cyclopamine-treated embryos have severe edema at tadpole
stages (100%, N=79, Fig. 5B), in addition to axial and gut-looping
defects expected upon loss of Hh signaling (Fig. 6J and not shown).
Subcutaneously-injected dye, which is usually pumped into the
pronephric sinus by the lymph hearts and cleared within an hour
(Fig. 5C), ﬁlls the coelomic cavity and is retained in cylopamine-
Fig. 4. The timing of Hedgehog induction of lymph hearts corresponds to the onset of en1 expression. Cyclopamine or ethanol (as a solvent control) was added to embryos at the
speciﬁed developmental stages; tadpoles were ﬁxed at stages 42–45, and stained with 12/101 for presence of lymph heart musculature. The ethanol controls for all stages are
combined in this graph, but χ2 tests were performed between stage-matched cyclopamine and control samples for determination of statistical signiﬁcance. Cyclopamine treatment
has a less potent effect when added after stage 20 (4% wild type at st. 20 vs. 35% wild type at st. 22). Experimental and control samples are not signiﬁcantly different when embryos
are added to cyclopamine at stage 26, just prior to en1 expression in lymph heart myoblasts, or later in development (⁎pb0.01).
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required to specify the musculature for functional lymph hearts; since
lymphatic defects result in edema (Ny et al., 2005), we could
potentially conclude that edema results in cyclopamine-treated
embryos from non-functional lymph hearts. However, edema can be
associated with impairment in cardiovascular and renal function, in
addition to lymphatic function, and Hh signaling is required for
numerous developmental processes. Indeed, while most cyclopa-
mine-treated embryos have beating hearts, in many the cardiac
chambers do not ﬁll with blood and no blood circulation is observed in
the tail or gills. These observations implicate a vasculature defect
upon inhibition of Hh signaling, which may contribute to the
development of edema and/or the recruitment of lymph heart
myoblasts from the somites. Thus, we examined expression of several
vascular markers in cyclopamine-treated embryos (Supplemental
Figure 2).
Cardiovascular markers (Msr, VEGF, and Flk-1) were unperturbed
in the area of the lymph heart prior to en1 expression in cyclopamine-
treated embryos (st. 24–25, Figure S2A–B, E–F, I–J). In addition,
development of the heart, aortic arch arteries, dorsal aorta, inter-
somitic vessels, pronephric sinus, and ventral blood islands appear
normal. At the time of en1 onset in lymph heart myoblasts (stage 28,
Figure S2C–D, G–H, K–L), cyclopamine-treated embryos have in-
creased Msr and Flk1 expression in the posterior cardinal vein (PCV,
Figure S2D, L, arrows) and decreased VEGF expression in the glomus
(Figure S2H, arrowhead). However, all markers seem to be expressed
normally in vasculature surrounding the lymph heart, indicating that
lymph heart musculature does not fail to be recruited secondary to
reduced blood supply in these embryos. Nonetheless, it is quite
possible that the observed changes in the PCV architecture contribute
to the edema and circulatory defects observed at tadpole stages in
cyclopamine-treated embryos.
To address whether cyclopamine-induced edemamight be speciﬁc
to defective lymph heart function, we selectively paralyzed the lymph
heart with a mild anesthetic (benzocaine) treatment. While high
doses of benzocaine inhibit all muscle function, mild benzocaine
treatment (0.01%–0.005%) paralyzes skeletal and lymph heart muscle,
while preserving cardiac muscle function. Over 24 h of impaired
lymph heart function, tadpoles develop severe edema, which
resembles the edema phenotype in cyclopamine-treated embryos
(Fig. 5F; 100%, N=60). The cardiac hearts beat but are not ﬁlled withblood, and blood pools in the kidney, lymph heart, and gills (Fig. 5F,
arrows). As anesthetic was added after development of the vascula-
ture and is not expected to affect vasculogenesis, blood pooling
suggests that skeletal muscle contractions might be required for
efﬁcient cardiovascular circulation. The lymphedema and blood
circulation defects were largely recovered within 4 days by returning
embryos to culture media without benzocaine to allow the lymph
heart to start beating again (Fig. 5H; 58% recovered, N=57).
While these results support the conclusion that loss of lymph heart
beating results in edema, they do not prove that the cyclopamine-
induced edema results directly from loss of lymph heart myoblasts. In
fact, we had seen vascular and renal capsule (glomus) defects upon
loss of Hh signaling (Figure S2), whichmay cause edema or compound
the effect of lymph heart dysfunction. To address this correlation, we
examined whether the development of the edema phenotype in
cyclopamine-treated embryos coincideswith the onset of lymph heart
beating. Embryos placed in cyclopamine from stage 8 onwards
develop severe edema and other hallmark Hh loss-of-function
phenotypes, such as narrowly spaced eyes (Fig. 6J). In a time–course
observation of these embryos, it is clear that swelling begins earlier
than the onset of lymph heart beating at stages 41–42; edema begins
around the kidney area, as early as stage 33 (Fig. 6B, arrow) and is
clear at stage 35/36 (Fig. 6D, arrow). Edema continues to develop so
that it is severe at stage 40 (Fig. 6H, arrow). Because the onset of
edema in cyclopamine-treated embryos precedes lymph heart
beating, it cannot be caused solely by loss of lymph heart musculature,
though our benzocaine experiments indicate that loss of lymph heart
function would exacerbate pre-existing edema. Perhaps circulatory
defects due to mispatterned vasculature are the primary cause of
edema in cyclopamine-treated embryos. Alternatively, since swelling
begins around the kidney, it is possible that kidney speciﬁcation or
function, as well as lymph heart myogenesis, is affected by loss of Hh
signaling. We are currently investigating this possibility.
Engrailed-1 is required for lymph heart musculature
We have shown that Hh signaling is required for expression of
engrailed-1, the earliest marker we have found of lymph heart
myoblasts, and that the requirement for Hh signaling in lymph heart
musculature coincides with the onset of en1 expression. These results
suggest that loss of Engrailed-1 function in cyclopamine-treated
Fig. 5. Lymph heart paralysis results in reversible edema. Cylopamine treatment from stage 8 results in loss of lymph heart beating and severe edema at stage 42 (B; 100%, N=79).
Florescent dye injected subcutaneously into the ﬁn of cyclopamine-treated tadpoles (stage 42) ﬁlls the body cavity and fails to clear the body in an hour (D), unlike in controls (C).
Tadpoles with visibly beating lymph hearts (st. 42+) were placed in a dilute benzocaine solution (0.005%–0.01%), which resulted in lymph heart paralysis while leaving the cardiac
heartbeat unaffected. After 24 h of lymph heart paralysis, tadpoles developed severe edema with blood pooling in the kidney, lymph heart, and gills (F, arrows; 100%, N=60), while
control tadpoles did not (E). Removal of these embryos from benzocaine restored lymph heart function and tadpoles were mostly recovered in 4 days (H; 58%, N=57, compare to G,
control).
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whether En1 is required for the speciﬁcation of lymph heart
musculature, we performed morpholino knockdown. With two non-
overlapping MOs designed to block en1 translation, we obtained
similar results to Hh signaling inhibition with cyclopamine. Bilateral
injection of En1MO led to loss of beating lymph hearts and subsequent
edema (100%, N=46; Figs. 7A–C), which began after stage 41 andwas
less severe than with cyclopamine or benzocaine treatment, without
circulation defects. This speciﬁc result strengthens our hypothesis that
loss of skeletal muscle contractions in benzocaine-treated tadpoles
results in blood-pooling, as well as our conclusion that cyclopamine-
induced edema results from additional causes other than lymph heart
dysfunction. Unilateral injection of En1 MO resulted in loss of lymph
heart musculature on the injected side, assayed by en1 (79%, N=34;
Figs. 7D–F) andMyoD expression (100%, N=13; data not shown) and
12/101 staining (95%, N=80; Figs. 7G–I). However, paraxial meso-derm and prox1 expression in the endothelium were mostly
unaffected (Figs. 7K, L; 64% wt, N=47 for En1 morphants vs. 58% wt,
N=19 for controls). These results from En1 knockdown recapitulate
the phenotype of cyclopamine treatment.
Due to the highly speciﬁc spatio-temporal expression of en1 and
its potent transcriptional repression activity, we were unable to
perform traditional rescue experiments to determine the speciﬁcity of
En1 MOs. However, we believe we have achieved speciﬁc En1
knockdown, as we obtained the same results with two non-over-
lappingMOs, and observed phenotypes were speciﬁc to the tissue that
expresses en1, i.e., the lymph heart myoblasts, as opposed to
lymphatic endothelium or other musculature. In addition, we
observed edema that coincided in time with the onset of lymph
heart beating, with no obvious effect on circulation or locomotion. Our
results indicate that Engrailed-1 is required for speciﬁcation of lymph
heart myoblasts, downstream of Hh signaling.
Fig. 6. The development of edema upon cyclopamine treatment does not correspond to lymph heart beating. Embryos were added to cyclopamine (B, D, F, H, and J) at stage 8 and
compared to controls (A, C, E, G, and I) at stage 33/34 (A, B), st. 35/36 (C, D), st. 37/38 (E, F), st. 40 (G, H), and st. 45 (I, J). Edema begins around the kidney area as early as st. 33/34
(B, arrow) and continues to worsen (D, F, and H, arrows), long before the lymph hearts start beating (st. 41–42).
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Anterior lymph heart myoblasts represent a somitic cell lineage
that shares similarity to teleost muscle pioneer cells, which also
express en1 and require Hh signals. They also demonstrate the
plasticity of somite-derived myoblasts in that they possess the ability
to form “cardiac-like” skeletal muscle, despite not expressing cardiacspeciﬁcation or differentiation markers, such as GATA genes and
cardiac troponin. The lymph heart musculature, which forms the
tunica media, is under distinct developmental control from the
endothelial tissue, which forms the tunica intima. Loss of Hh signaling
or Engrailed-1 function causes an absence of lymph heart muscle, but
does not affect the endothelial tissue. Mammals do not possess
beating lymph hearts, but instead have a jugular (endothelial) lymph
Fig. 7. Engrailed-1 is required for lymph heart myogenesis. Two non-overlapping MOs were designed to block en1 translation. Bilateral injection of En1 MO leads to loss of lymph
heart beat and edema (A–C). Unilateral injection of En1 MO leads to speciﬁc loss of lymph heart musculature assayed by en1 expression (D–F, ⁎pb0.05 χ2 test) and 12/101 staining
(G–I, dorsal view, arrow points to lymph heart, asterisk indicates injected side). In controls, 100% of embryos have two 12/101-positive lymph hearts (N=43), while 5% of En1
morphants do (En1 MO1 N=42, En1 MO2 N=38). Lymph heart endothelium (prox1, J–L) is not affected by En1 knockdown compared to controls (pN0.05, χ2 test).
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hearts in frogs. This evolutionary transition may have been facilitated
due to the separate pathways regulating lymph heart myoblasts vs.
endothelial tissue.
It is likely that Hh signaling is permissive for lymph heart myoblast
induction, as there is no localized expression of Hh genes in somites 3
and 4, from which the anterior lymph heart myoblasts arise. In
addition, Shh overexpression does not induce ectopic or larger lymph
hearts (not shown), and the Hh receptor and target gene Patched is
not prominently co-expressed with en1. Indeed, it is possible that
inhibition of Hh signaling results in loss of lymph heart myoblasts
indirectly, through its effects on somite patterning and differentiation.
We have shown that loss of Hh signaling expands the dermamyotome
(Martin et al., 2007), the area fromwhich en1-expressing lymph heart
myoblasts seem to arise (Figs. 2E, F). Thus, loss of Hh signaling may
keep the dermamyotome in a non-differentiated state at a crucial
time-point for the lymph heart, not allowing for the differentiation of
en1-positive lymph heart myoblasts.
Upon loss of lymph heart musculature (in cyclopamine-treated
embryos and En1 morphants) or lymph heart beating (through
benzocaine-induced paralysis), we observed edema in tadpole
embryos. En1 MO-induced edema is likely speciﬁcally due to failure
of lymph heart myogenesis, as we saw no obvious defects in tissues
other than the lymph heart musculature, and edema resulted only
after the time when the lymph hearts normally start to beat.
Benzocaine treatment paralyzes skeletal muscle contractions and
the lymph hearts, while leaving the cardiac heart beat intact.
Benzocaine-induced edema was more severe than that observed in
En1 morphants, with reduced blood circulation and pooling in the
kidney, lymph heart, and gills. As the only difference between these
embryos and En1 morphants is the paralysis of skeletal muscle, we
hypothesize that skeletal muscle contractions help to circulate blood,
and perhaps lymph, in Xenopus tadpoles. In mammals, which do notpossess lymph hearts, skeletal muscle contractions serve to circulate
lymph throughout the body.
Interestingly, blockade of Hh signaling induced edema earlier in
development, prior to the onset of lymph heart beating at stages
41–42, indicating an alternate cause. Edema is associated with
defects in cardiac, renal, and lymphatic systems. While the cardiac
heart develops upon inhibition of Hedgehog signaling, we observed
some abnormal expression of vasculature markers in the posterior
cardinal vein, which may lead to circulatory defects and edema in
these embryos. It is also possible that Hh signaling is required for
kidney development in Xenopus laevis. Upon inhibition of Hh
signaling, edematous swelling begins around the kidney at around
the time it begins to be functional (stages 37–38), supporting this
hypothesis. In addition, VEGF expression in the glomus is decreased
in cyclopamine-treated embryos. Previously, ectopic Hh signaling
has been shown to repress development of the pronephric duct and
tubule through repression of Fgf8, which is required for condensa-
tion and epithelialization (Urban et al., 2006). We are currently
performing loss-of-function experiments to establish whether
kidney development is compromised in the absence of Hh signaling
as well.
These results emphasize the importance of Hedgehog signaling in
the organogenesis of lower vertebrates, in which there are differences
in the Hh requirements for formation of somitic derivatives, such as
muscle pioneers in teleosts and hypaxial musculature and lymph
heart myoblasts in amphibians. We further establish the usefulness of
Xenopus in the study of ﬂuid balance through the action of the heart,
lymphatic system and pronephros.
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